期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

^131I扫描与断层显像定量分析甲状腺病灶的比较 被引量：3

原文传递
导出
摘要 ^131I治疗可提高DTC患者术后生存率。然而，目前^131I治疗常采用固定剂量法，明确病灶的摄碘能力以及部位、数目，可为个体化^131I治疗提供依据。
作者 李建芳 程木华 许杰华 张峰
机构地区 中山大学附属第三医院核医学科
出处 《中华核医学与分子影像杂志》 CSCD 北大核心 2012年第3期222-223,共2页 Chinese Journal of Nuclear Medicine and Molecular Imaging
关键词 ^131I 定量分析 断层显像 病灶 甲状腺 扫描 术后生存率 固定剂量法
分类号 R817 [医药卫生—影像医学与核医学]
  • 相关文献

参考文献4

  • 1余永利,罗全勇,陈立波,罗琼,丁颖,陆汉魁,朱瑞森,马寄晓.分化型甲状腺癌术后~131Ⅰ治疗生存率分析[J].中华核医学杂志,2006,26(5):261-263. 被引量：21
  • 2American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer,Cooper DS,Doherty GM. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J].Thyroid:Official Journal of the American Thyroid Association,2009.1167-1214.
  • 3Maxon HR 3rd,Englaro EE,Thomas SR. 131I therapy for well-differentiated thyroid cancer-a quantitative radiation dosimetric approach:outcome and validation in 85 patients[J].Journal of Nuclear Medicine,1992.1132-1136.doi:10.1016/j.ejso.2008.10.002.
  • 4Yamamoto Y,Nishiyama Y,Monden T. Clinical usefulness of fusion of 131I SPECT and CT images in patients with differentiated thyroid carcinoma[J].The Journal of Nuclear Medicine,2003.1905-1910.

二级参考文献8

  • 1Kouvaraki MA,Shapiro SE,Lee JE,et al.Surgical management of thyroid carcinoma.J Natl Compr Canc Netw,2005,3:458-466.
  • 2Mazzaferri EL,Kloos RT.Current approaches to primary therapy for papillary and follicular thyroid cancer.J Clin Endocrinol Metab,2001,86:1447-1463.
  • 3Hay ID,Thompson GB,Grant CS,et al.Papillary thyroid carcinoma managed at the Mayo Clinic during six decades(1940-1999):temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients.World J Surg,2002,26:879-885.
  • 4Derey TW,Paul GG.Role of 131I in the treatment of well differentiated thyroid cancer.J Gurg Oncol,2005,89:114-121.
  • 5Parthasarathy KL,Crawford ES.Treatment of thyroid carcinoma:emphasis on high-dose 131I outpatient therapy.J Nucl Med Technol,2002,30:165-171.
  • 6Yamashita HM.Locally recurrent thyroid carcinoma.In:Noguchi OHCaS,eds.Thyroid cancer:diagnosis and treatment.St.Louis:Quality Medical Publishing,Inc,2000.312-321
  • 7Sophie L,Carole R,Eric B,et al.Prognosis factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis.J Clin Endocrinol Metab,2005,90:1210-1215.
  • 8Liu JD,Hsieh SH,Chang HY,et al.Outcome after treatment for papillary thyroid cancer.Head Neck,2001,23:140-146.

共引文献20

同被引文献36

  • 1Noussios G, Anagnostis P, Goulis DG, et al. Ectopic thyroid tissue:Anatomieal, clinical, and surgical implications of a rare entity[M]. Eur J Endocrinol,2011,165(3) :375 .
  • 2Kabal JE. Computed tomography and magnetic resonance imaging in Diseases of the thyroid and parathyroid[J]. EJR, 2008,66(4) :480-492.
  • 3SILBERSTEIN E B. The problem of the patient with thyro- globulin elevation but negative Iodine scintigraphy the TE- NIS syndrome [J]. Semin Nucl Med, 2011, 41(2) : 113-120.
  • 4SONG H J, XUE Y L, QIU Z L, et al. Uncommon metasta- ses from differentiated thyroid carcinoma[J]. Hell J Nucl Med, 2012, 15(3): 233-240.
  • 5ADEDAPO K S, VANGU M D. Data on repeated (131)I-WB scans and the incidence of positive Tg and negative (131)I- WBS in DTC patients from a 24 months study [J]. Hell J Nu- el Med, 2011, 14(2): 131-134.
  • 6CHINDRIS A M, DIEHL N N, CROOK J E, et at. Unde- tectable sensitive serum thyroglobulin (<0. lng/ml) in 163 patients with follicular cell-derived thyroid caneer: results of rhTSH stimulation and neck ultrasonography and long-term biochemical and clinical follow-up [J]. J Clin Endoerinol Metab, 2012, 97(8): 2714-2723.
  • 7MIZRACHI A, FEINMESSER R, BACHAR G, et al. Value of ultra Jound detectg central eotrLpartment lymph node metastases in differentiated thyroid carcinoma [J]. Eur Arch Otorhinolaryngol, 2013.
  • 8PALANISWAMY S S, SUBRAMANYAM P. Diagnostic u- tility of PETCT in thyroid malignancies: an update[J].Ann Nucl Med, 2013, 27(8): 681-693.
  • 9HONG C M, AHN B C, JEONG S Y, et al. Distant meta- static lesions in patients with differentiated thyroid eareino-ma. clinical implications of radioiodine and FDG uptake [J]. Nuklearmedizin, 2013, 52(4): 121-129.
  • 10VURAL G U, AKKAS B E, ERCAKMAK N, et al. Prog- nostic significance of FDG PET/CT on the follow-up of pa- tients of differentiated thyroid carcinoma with negative 131I whole-body scan and elevated thyroglobulin levels: correlation with elinieal and histopathologic characteristics and long-term follow-up data[J]. ClinNuclMed, 2012, 37(10): 953-959.

引证文献3

二级引证文献9

中华核医学与分子影像杂志
2012年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部